# Tirofiban

## Aggrastat inj 12.5mg/50mL

| TAH Drug Code      | [IAGG](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IAGG)                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | When used in combination with heparin, AGGRASTAT is indicated for the prevention of ischemic cardiac events in patients with unstable angina or non-Q-wave myocardial infarction (non-ST elevation acute coronary syndrome, NSTE-ACS). It is also used to prevent ischemic cardiac complications caused by abrupt coronary artery closure in patients with coronary artery ischemic symptoms undergoing percutaneous coronary intervention (PCI). |
| Dosing             | Non-ST elevation acute coronary syndromes: (combined with heparin) loading infusion rate as 0.4 mcg/kg/min for 30 minutes, followed by 0.1 mcg/kg/min as maintenance infusion rate for at least 48 hours, up to 108 hours. Percutaneous coronary intervention: (combined with heparin) initial bolus 25 mcg/kg for at least 3 minutes, followed by 0.15 mcg/kg/min as maintenance infusion rate for 12-24 hours, do not more than 48 hours.       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Severe hypersensitivity reaction (ie, anaphylactic reaction) to tirofiban or any component of the formulation; history of thrombocytopenia following prior exposure to tirofiban; active internal bleeding or a history of bleeding diathesis, major surgical procedure, or severe physical trauma within the previous month.                                                                                                                     |
| Adverse Effects    | >10%: Minor hemorrhage 1% to 10%:Coronary artery dissection, bradycardia, edema, vasodepressor syncope, dizziness, headache, diaphoresis, nausea, pelvic pain, major hemorrhage, leg pain, fever.                                                                                                                                                                                                                                                 |
| Pregnancy          | Compatible â€“ Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | Hold Breast Feeding                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/tirofiban-drug-information)                                                                                                                                                                                                                                                                                                                                                                          |

